美國醫療低溫運輸包裝市場規模、佔有率和趨勢分析報告：按產品、包裝類型、溫度要求、應用和細分市場預測，2026-2033年

市場規模與趨勢：

據估計，2025年美國醫療低溫運輸包裝市值為37.2億美元，預計2033年將達到93.2億美元。

預計從 2026 年到 2033 年，該行業將以 12.2% 的複合年成長率成長，這主要得益於對溫度敏感的藥品（尤其是生物製藥、疫苗、細胞和基因療法以及高度專業化的藥物）的開發和分銷不斷增加。

這些產品在儲存和運輸過程中通常需要精確的溫度控制，以保持其功效和效力。例如，mRNA疫苗和許多單株抗體即使在溫度發生微小波動時也會失去效力，因此高性能的隔熱包裝和超低溫解決方案至關重要。

隨著製藥公司不斷將重點從傳統小分子藥物轉向生物製藥和個人化醫療，它們對可靠的低溫運輸包裝的依賴也迅速增強。在美國醫療保健市場，受製藥創新、醫療服務模式、法律規範以及供應鏈風險管理等方面的結構性變革的推動，對低溫運輸包裝的需求正在穩步成長。過去，低溫運輸要求僅限於少數疫苗和生物製藥，而如今，溫度控制已成為涵蓋廣泛且不斷成長的醫療產品領域的基本要求。

推動市場成長的關鍵因素之一是溫度敏感型藥品（尤其是生物製藥、特藥、疫苗以及細胞和基因療法等先進治療方法）的快速成長。這些產品在狹窄的溫度範圍之外極不穩定，即使短暫暴露於溫度變化中，也可能失去效力或失效。隨著美國藥物開發平臺生物製藥產品而非傳統小分子藥物的比例不斷上升，需要冷藏、冷凍和超低溫保存的產品數量也顯著增加。因此，製藥公司正大力投資檢驗的低溫運輸包裝解決方案，以確保產品在長距離運輸和複雜的通路中保持熱穩定性。

與此趨勢密切相關的是美國生物製藥研究、臨床試驗和商業化的強勁成長。美國承擔全球大部分臨床試驗，其中許多試驗涉及在嚴格的溫度控制下，將臨床實驗藥物從製造地運送到測試機構、實驗室和儲存設施。這些運輸涉及長途跋涉和多次交接，增加了溫度波動的風險。因此，對高性能隔熱包裝、相變材料和經認證的運輸系統的需求日益成長，這些系統能夠在整個研究週期中保持溫度的穩定性。

目錄

第1章調查方法和範圍

第2章執行摘要

3. 美國醫療低溫運輸包裝市場變數、趨勢與範圍

• 市場譜系展望
• 產業價值鏈分析
• 技術概述
• 供需差距分析（2025 年）
• 永續性趨勢
• 法律規範
• 市場動態
• 商業環境分析
  • 波特五力分析
  • PESTEL 分析

第4章：美國醫療低溫運輸包裝市場：按產品分類的估價與趨勢分析

• 產品特定波動分析及市場佔有率（2025 年和 2033 年）
  • 保溫托盤運輸
  • 保溫容器
  • 真空絕熱板
  • 冷卻包和冷媒
  • 標籤感測器
  • 其他

第5章 美國醫療低溫運輸包裝市場：按包裝類型分類的估價與趨勢分析

• 按包裝形式和市場佔有率分類的變化分析（2025 年和 2033 年）
  • 積極的
  • 被動的

第6章：美國醫療低溫運輸包裝市場：依溫度要求分類的估價與趨勢分析

• 按溫度需求分類的變化分析和市場佔有率（2025 年和 2033 年）
  • 室溫控制（CRT）
  • 冷藏（2 度C至8 度C）
  • 冷凍（-20 度C至 -40 度C）
  • 低溫（低於-80 度C）

第7章：美國醫療低溫運輸包裝市場：按應用分類的估價與趨勢分析

• 按應用領域分類的趨勢分析和市場佔有率（2025 年和 2033 年）
  • 生物製藥公司
  • 臨床研究所
  • 醫院和醫療保健機構
  • 研究機構和實驗室
  • 物流/配送公司
  • 其他

第8章 競爭情勢

• 主要企業和近期趨勢及其對該行業的影響
• 供應商概況
  • 公司分類
  • 潛在原料供應商和通路夥伴名單
• 競爭動態
  • 市佔率分析
  • 企業市場分析
  • 策略規劃

第9章 公司列表（概述、財務表現、產品概述）

• Sealed Air Corporation
• Peli BioThermal LLC
• CSafe
• DGP Intelsius LLC
• ThermoSafe Technologies Inc.
• Cryoport Systems, LLC

Market Size & Trends:

The U.S. healthcare cold chain packaging market size was estimated at USD 3.72 billion in 2025 and is projected to reach USD 9.32 billion by 2033, growing at a CAGR of 12.2% from 2026 to 2033. This is attributed to the increasing development and distribution of temperature-sensitive drugs, especially biologics, vaccines, cell and gene therapies, and advanced specialty medicines.

These products often require precise thermal conditions throughout storage and transportation to retain potency and efficacy. For example, mRNA-based vaccines and many monoclonal antibodies lose effectiveness if exposed to even minor temperature variations, necessitating high-performance insulated packaging and ultracold solutions.

As pharmaceutical companies continue to shift focus from traditional small-molecule drugs toward biologics and personalized medicines, the reliance on robust cold chain packaging has surged. The demand for cold chain packaging in the U.S. healthcare market is expanding steadily, driven by structural shifts in pharmaceutical innovation, healthcare delivery models, regulatory oversight, and supply-chain risk management. Unlike earlier periods when cold chain requirements were limited to a narrow set of vaccines and biologics, temperature control has now become a foundational requirement across a broad and growing segment of healthcare products.

A primary factor driving the growth is the rapid increase in temperature-sensitive pharmaceuticals, particularly biologics, specialty drugs, vaccines, and advanced therapies such as cell and gene treatments. These products are inherently unstable outside narrow temperature ranges and can lose potency or become unusable if exposed to even brief temperature excursions. The U.S. pharmaceutical pipeline is increasingly dominated by biologics rather than traditional small-molecule drugs, which significantly raises the volume of products requiring refrigerated, frozen, or ultra-cold conditions. As a result, pharmaceutical manufacturers are investing heavily in validated cold chain packaging solutions that can ensure thermal stability across long and complex distribution routes.

Closely linked to this trend is the strong growth in biopharmaceutical research, clinical trials, and commercialization activity within the U.S. The country hosts a large share of global clinical trials, many of which involve investigational drugs that must be transported between manufacturing sites, trial centers, laboratories, and storage facilities under strict temperature controls. These shipments often span long distances and multiple handovers, increasing the risk of temperature deviation. Consequently, demand is rising for high-performance insulated packaging, phase-change materials, and qualified shipping systems that can maintain temperature integrity throughout the trial lifecycle.

U.S. Healthcare Cold Chain Packaging Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. healthcare cold chain packaging market report based on product, temperature requirement, packaging format, and application:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Insulated Pallet Shippers
• Insulated Containers
• Vacuum Insulated Panels
• Cold Packs & Refrigerants
• Labels & Sensors
• Others
• Temperature Requirement Outlook (Revenue, USD Million, 2021 - 2033)
• Controlled Room Temperature (CRT)
• Refrigerated (2°C-8°C)
• Frozen (-20°C to -40°C)
• Cryogenic (<-80°C)
• Packaging Format Outlook (Revenue, USD Million, 2021 - 2033)
• Active
• Passive
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceutical Companies
• Clinical Research Organizations
• Hospitals and Healthcare Providers
• Research Institutes & Labs
• Logistics and Distribution Companies
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Research Methodology
  • 1.1.1. Market Segmentation
  • 1.1.2. Market Definition
• 1.2. Research Scope & Assumptions
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing
• 1.7. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot, (USD Million)
• 2.2. Segmental Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Healthcare Cold Chain Packaging Market Variables, Trends, and Scope

• 3.1. Market Lineage Outlook
• 3.2. Industry Value Chain Analysis
• 3.3. Technology Overview
• 3.4. Supply Demand Gap Analysis, 2025
• 3.5. Sustainability Trends
• 3.6. Regulatory Framework
• 3.7. Market Dynamics
  • 3.7.1. Market Driver Analysis
  • 3.7.2. Market Restraint Analysis
  • 3.7.3. Market Challenge Analysis
• 3.8. Business Environment Analysis
  • 3.8.1. Porter's Five Forces Analysis
  • 3.8.2. PESTEL Analysis

Chapter 4. U.S. Healthcare Cold Chain Packaging Market: Product Estimates & Trend Analysis

• 4.1. Key Takeaways
• 4.2. Product Movement Analysis & Market Share, 2025 & 2033
  • 4.2.1. Insulated Pallet Shippers
    • 4.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.2. Insulated Containers
    • 4.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.3. Vacuum Insulated Panels
    • 4.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.4. Cold Packs & Refrigerants
    • 4.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.5. Labels & Sensors
    • 4.2.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.6. Others
    • 4.2.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Healthcare Cold Chain Packaging Market: Packaging Format Estimates & Trend Analysis

• 5.1. Key Takeaways
• 5.2. Packaging Format Movement Analysis & Market Share, 2025 & 2033
  • 5.2.1. Active
    • 5.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.2.2. Passive
    • 5.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Healthcare Cold Chain Packaging Market: Temperature Requirement Format Estimates & Trend Analysis

• 6.1. Key Takeaways
• 6.2. Temperature Requirement Movement Analysis & Market Share, 2025 & 2033
  • 6.2.1. Controlled Room Temperature (CRT)
    • 6.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.2.2. Refrigerated (2°C-8°C)
    • 6.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.2.3. Frozen (-20°C to -40°C)
    • 6.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.2.4. Cryogenic (<-80°C)
    • 6.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Healthcare Cold Chain Packaging Market: Application Format Estimates & Trend Analysis

• 7.1. Key Takeaways
• 7.2. Application Movement Analysis & Market Share, 2025 & 2033
  • 7.2.1. Biopharmaceutical Companies
    • 7.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.2. Clinical Research Organizations
    • 7.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.3. Hospitals and Healthcare Providers
    • 7.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.4. Research Institutes & Labs
    • 7.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.5. Logistics and Distribution Companies
    • 7.2.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.6. Others
    • 7.2.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Key Players & Recent Developments & Their Impact on the Industry
• 8.2. Vendor Landscape
  • 8.2.1. Company Categorization
  • 8.2.2. List of Potential Raw Material Suppliers & Channel Partners
• 8.3. Competitive Dynamics
  • 8.3.1. Market Share Analysis
  • 8.3.2. Company Market Position Analysis
  • 8.3.3. Strategy Mapping
    • 8.3.3.1. Expansions
    • 8.3.3.2. Mergers & Acquisitions
    • 8.3.3.3. Collaborations
    • 8.3.3.4. New Product Launches
    • 8.3.3.5. Others

Chapter 9. Company Listing (Overview, Financial Performance, Product Overview)

• 9.1. Sealed Air Corporation
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
• 9.2. Peli BioThermal LLC
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
• 9.3. CSafe
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
• 9.4. DGP Intelsius LLC
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
• 9.5. ThermoSafe Technologies Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
• 9.6. Cryoport Systems, LLC
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking

List of Tables

• Table 1 U.S. Healthcare Cold Chain Packaging Market Revenue Estimates and Forecasts, By Product, 2021 - 2033 (USD Million)
• Table 2 U.S. Healthcare Cold Chain Packaging Market Revenue Estimates and Forecasts, By Packaging Format, 2021 - 2033 (USD Million
• Table 3 U.S. Healthcare Cold Chain Packaging Market Revenue Estimates and Forecasts, By Temperature Requirement, 2021 - 2033 (USD Million)
• Table 4 U.S. Healthcare Cold Chain Packaging Market Revenue Estimates and Forecasts, By Application, 2021 - 2033 (USD Million)
• Table 5 Recent Developments & Impact Analysis, By Key Market Participants

List of Figures

• Fig. 1 Market Segmentation & Scope
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Primary Research Process
• Fig. 5 Market Research Approaches - Bottom-Up Approach
• Fig. 6 Market Research Approaches - Top-Down Approach
• Fig. 7 Market Research Approaches - Combined Approach
• Fig. 8 U.S. Healthcare Cold Chain Packaging Market: Market Insights (USD Million)
• Fig. 9 U.S. Healthcare Cold Chain Packaging Market: Segmental Insights (USD Million) (1/2)
• Fig. 10 U.S. Healthcare Cold Chain Packaging Market: Segmental Insights (USD Million) (2/2)
• Fig. 11 U.S. Healthcare Cold Chain Packaging Market: Competitive Outlook
• Fig. 12 U.S. Healthcare Cold Chain Packaging Market: Industry Value Chain Analysis
• Fig. 13 Market Dynamics
• Fig. 14 Median Age, 2000 - 2030 (Years)
• Fig. 15 U.S. Healthcare Cold Chain Packaging Market: Porter's Five Forces Analysis
• Fig. 16 U.S. Healthcare Cold Chain Packaging Market: PESTEL Analysis
• Fig. 17 U.S. Healthcare Cold Chain Packaging Market: Key Takeaways
• Fig. 18 U.S. Healthcare Cold Chain Packaging Market, By Product: Market Share, By Revenue, 2025 & 2033 (%)
• Fig. 19 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Insulated Pallet Shippers, 2021 - 2033 (USD Million)
• Fig. 20 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Insulated Containers, 2021 - 2033 (USD Million)
• Fig. 21 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Vacuum Insulated Panels, 2021 - 2033 (USD Million)
• Fig. 22 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Cold Packs & Refrigerants, 2021 - 2033 (USD Million)
• Fig. 23 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Labels & Sensors, 2021 - 2033 (USD Million)
• Fig. 24 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Other Products, 2021 - 2033 (USD Million)
• Fig. 25 U.S. Healthcare Cold Chain Packaging Market: Key Takeaways
• Fig. 26 U.S. Healthcare Cold Chain Packaging Market, By Packaging Format: Market Share, By Revenue, 2025 & 2033 (%)
• Fig. 27 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Passive Packaging, 2021 - 2033 (USD Million)
• Fig. 28 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Active Packaging, 2021 - 2033 (USD Million)
• Fig. 29 U.S. Healthcare Cold Chain Packaging Market: Key Takeaways
• Fig. 30 U.S. Healthcare Cold Chain Packaging Market, By Temperature Requirement: Market Share, By Revenue, 2025 & 2033 (%)
• Fig. 31 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Controlled Room Temperature (CRT), 2021 - 2033 (USD Million)
• Fig. 32 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Refrigerated (2°C-8°C), 2021 - 2033 (USD Million)
• Fig. 33 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Frozen (-20°C to -40°C), 2021 - 2033 (USD Million)
• Fig. 34 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Cryogenic (<-80°C), 2021 - 2033 (USD Million)
• Fig. 35 U.S. Healthcare Cold Chain Packaging Market: Key Takeaways
• Fig. 36 U.S. Healthcare Cold Chain Packaging Market, By Application: Market Share, By Revenue, 2025 & 2033 (%)
• Fig. 37 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, For Biopharmaceutical Companies, 2021 - 2033 (USD Million)
• Fig. 38 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, For Clinical Research Organizations, 2021 - 2033 (USD Million)
• Fig. 39 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, For Hospitals and Healthcare Providers, 2021 - 2033 (USD Million)
• Fig. 40 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, For Research Institutes & Labs, 2021 - 2033 (USD Million)
• Fig. 41 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, For Logistics and Distribution Companies, 2021 - 2033 (USD Million)
• Fig. 42 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, For Other Applications, 2021 - 2033 (USD Million)
• Fig. 43 U.S. Healthcare Cold Chain Packaging Market: Company Market Share Analysis, 2025
• Fig. 44 U.S. Healthcare Cold Chain Packaging Market: Competitive Benchmarking
• Fig. 45 Strategy Mapping